PMV Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PMVP research report →
About the company
PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. Their leading experimental drug, PC14586, is a small molecule designed to correct the p53 protein specifically when it contains the Y220C mutation, thereby restoring its natural, functional state.
- CEO
- David H. Mack
- IPO
- 2020
- Employees
- 47
- HQ
- Princeton, NJ, US
Price Chart
- Market Cap
- $65.06M
- P/E
- -0.82
- P/S
- 0.00
- P/B
- 0.74
- EV/EBITDA
- -0.34
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -68.98%
- ROIC
- -94.79%
- Revenue
- $0 · 0.00%
- Net Income
- $-77,742,000 · -32.42%
- EPS
- $-1.48 · -30.03%
- Op Income
- $-86,206,000
- FCF YoY
- -41.72%
- 52W High
- $1.88
- 52W Low
- $1.02
- 50D MA
- $1.26
- 200D MA
- $1.30
- Beta
- 1.33
- Avg Volume
- 369.16K
Get TickerSpark's AI analysis on PMVP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 26 | Stelzer Laurie | other | 42,000 |
| Jun 4, 26 | LEVINE ARNOLD J | other | 42,000 |
| Jun 4, 26 | Gallagher Carol Giltner | other | 42,000 |
| Jun 4, 26 | Gallagher Carol Giltner | other | 42,000 |
| Jun 4, 26 | Gallagher Carol Giltner | other | 42,000 |
| Jun 4, 26 | FLOWERS KIRSTEN | other | 42,000 |
| Jun 4, 26 | BAUM CHARLES M | other | 42,000 |
| Mar 5, 26 | Carulli Michael | other | 240,000 |
| Mar 5, 26 | Ticktin Robert | other | 319,270 |
| Mar 5, 26 | Jalota Deepika | other | 303,310 |
Our PMVP coverage
Recent articles, reports, and earnings notes.
No research on PMVP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PMVP report →Similar companies
Peers in the same neighborhood.